Skip to main
University-wide Navigation

UK Study Shows Lower Lung Cancer Rates in Communities with Strong Smoke-free Laws

Communities with strong smoke-free workplace laws report lower number of new lung cancer diagnoses

Markey Awarded NCI Funding to Improve Tobacco Cessation Treatment

The University of Kentucky Markey Cancer Center is one of 22 cancer centers nationwide to receive funding to build and implement tobacco cessation treatment programs via the National Cancer Institute's Cancer Center Cessation Initiative (CCCI).

Working Outside the Box: How a Markey Lab is Helping Stroke Patients

In a prime example of the unique type of cross-collaboration that takes place at academic medical centers, Markey's stem cell lab is working together with the Kentucky Neuroscience Institute to bring an innovative stroke clinical trial to UK HealthCare.

UK Study Shows Cell Signaling Interaction May Prevent Key Step in Lung Cancer Progression

New findings from University of Kentucky faculty published in Scientific Reports reveals a novel cell signaling interaction that may prevent a key step in lung cancer progression.

Markey Joins Personalized Medicine Consortium to Speed Advances in Patient Care

The University of Kentucky Markey Cancer Center has joined the Oncology Research Information Exchange Network® (ORIEN), a personalized medicine consortium that allows its members to exchange data and push forward evidence-based cancer care to patients.

Markey's Blackburn Earns NIH New Innovator Award for Cancer Research

University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

KEHA Marks 40 Years of Support for UK Ovarian Cancer Research

What the Kentucky Extension Homemakers began four decades ago continues to make a profound difference in the lives of women across the Commonwealth.

UK-Authored Study Confirms Pelvic Radiation as Standard of Care for High-Risk, Early Stage Endometrial Cancer

In a new phase III trial report, recurrence and survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy & chemotherapy when compared with pelvic radiation therapy.

UK's Igniting Research Collaborations Program Yields Return On Investment for Team Science

UK's Igniting Research Collaborations (IRC) grant program has awarded nearly $300,000 in pilot grants to support interdisciplinary research.

Research Helps Drive Kentucky’s Economy

As Kentucky’s flagship research university, we are developing a well-educated workforce for the state. We are creating more jobs through smart growth and capital investment. And we are sustaining business and industry development through our research and commercialization.